EDUC vs REGN
Educational Development Corporation (EDUC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Educational Development Corporation (EDUC) is a publishing company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported EDUC revenue for 2026-02-28 was $22.9M. Net income was $2.3M. Revenue was up 245.3% from 2025-02-28 to 2026-02-28. EDUC currently screens at market cap $12.3M and trailing P/E 5.4.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
EDUC currently screens at market cap $12.3M and trailing P/E 5.4. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the EDUC and REGN stock pages for the full models.
Not investment advice.